NCT00907907View on ClinicalTrials.gov

Mycophenolate Mofetil Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Healthy
Interventions
DRUG

Mycophenolate Mofetil

Mycophenolate Mofetil Tablet 500 mg

DRUG

CellCept® Tablets

CellCept® Tablets, 500 mg

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00907907 - Mycophenolate Mofetil Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter